Mendelian Randomization reveals 60 inflammatory cytokines causally linked to cardiovascular, kidney, and metabolic diseases
Background
Observational studies have consistently linked systemic inflammation to the development and progression of cardiometabolic disorders. However, establishing a definitive causal relationship, especially across the interconnected organ systems involved in cardiovascular-kidney-metabolic (CKM) syndrome, remains a significant challenge. Current understanding often struggles to differentiate correlation from causation, hindering the development of targeted therapies. This study leverages genetic insights to clarify the causal roles of specific inflammatory cytokines in these complex, multi-organ pathologies.
Study Design
This Mendelian randomization (MR) study investigated causal links between 91 inflammatory cytokines and multiorgan dysfunction. Genetic instruments for these cytokines were obtained from the Olink Target Inflammation panel across 11 European-ancestry cohorts. The main analysis employed the inverse variance weighting (IVW) method, complemented by sensitivity analyses including MR-Egger and weighted median methods, to assess causal associations with cardiovascular, kidney, and metabolic traits.
Results
Genetically predicted levels of inflammatory cytokines showed widespread causal associations across CKM-related traits. A total of 60 cytokines exhibited at least one significant association. Specifically, 31 cytokines were causally linked to cardiovascular outcomes, 26 to kidney traits, 10 to obesity-related traits, and 21 to diabetes-related traits. These findings underscore the complex and often divergent roles of inflammatory mediators.
Notably, FGF5 and IL6 emerged as paradoxical regulators, exerting opposing causal effects across different organ systems, while MCSF was consistently identified as a pan-vascular risk amplifier for cardiovascular diseases.
Key Findings
- Genetically predicted inflammatory cytokine levels showed widespread causal associations across CKM-related traits.
- A total of 60 cytokines were causally linked to at least one cardiovascular, kidney, or metabolic outcome.
- 31 cytokines were associated with cardiovascular outcomes, 26 with kidney traits, 10 with obesity, and 21 with diabetes.
- FGF5 and IL6 exhibited paradoxical, opposing causal effects across different organ systems.
- MCSF was consistently identified as a pan-vascular risk amplifier for cardiovascular diseases.
Why It Matters
These findings provide critical causal evidence, shifting the understanding of inflammation in CKM syndrome from mere association to direct causation for many cytokines. This supports the development of precision therapeutic strategies that target specific inflammatory pathways based on the affected organ system or disease context. For clinicians and biohackers, this implies that a blanket anti-inflammatory approach may be less effective than a tailored one. The identification of paradoxical regulators like FGF5 and IL6 suggests that modulating these cytokines requires careful consideration of potential off-target effects across different organ systems, moving us closer to highly specific, context-dependent interventions.
mendelian-randomization
cytokines
inflammation
cardiovascular-disease
kidney-disease
metabolic-disease